申请人:Etat Français représenté par la Direction Centrale
Du Service de Santé des Armées
公开号:EP3945092A1
公开(公告)日:2022-02-02
The present invention relates to compounds for their use in the reactivation of butyrylcholinesterase. Such compounds are useful in the treatment or prevention of the intoxication with at least one organophosphorus nerve agent. The invention also relates to pharmaceutical compositions and kits comprising said compounds, and compounds per se.
本发明涉及化合物,用于重新激活丁酰胆碱酯酶。这些化合物在治疗或预防至少一种有机磷神经毒剂中毒方面是有用的。该发明还涉及包含所述化合物的药物组合物和试剂盒,以及化合物本身。